Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Stroke, 2015
Discovery of New Risk Markers for Ischemic Stroke Using a Novel Targeted Proteomics Chip

Lind L., Siegbahn A., Lindahl B. et al.

Olink Target 96CVDPatient StratificationPlasmaSerum

Thrombosis Research, 2015
Associations between circulating proteins and corresponding genes expressed in coronary thrombi in patients with acute myocardial infarction

Helseth R., Weiss T., Opstad T. et al.

Olink Target 96CVDPathophysiologyPlasma

Diabetes, 2015
Protein Biomarkers for Insulin Resistance and Type 2 Diabetes Risk in Two Large Community Cohorts

Nowak C., Sundström J., Gustafsson S. et al.

Olink Target 96Metabolic DiseasesPathophysiologyPlasmaSerum

Stroke, 2015
Fibroblast Growth Factor 23 and Incidence of Subarachnoid Hemorrhage

Söderholm M., Engström G.

Olink Target 96CVDPathophysiologyPatient Stratification

Journal of Pain Research, 2015
Evaluation of the protein biomarkers and the analgesic response to systemic methylene blue in patients with refractory neuropathic pain: a double-blind, controlled study

Miclescu A., Svahn M., Gordh T.

Olink Target 96NeurologyPatient StratificationPlasma

Cytokine, 2015
The body mass index (BMI) is significantly correlated with levels of cytokines and chemokines in cerebrospinal fluid

Larsson A., Carlsson L., Lind A. et al.

Olink Target 96Wider Proteomics StudiesEpidemiologyCSF

Atherosclerosis, 2015
Use of a proximity extension assay proteomics chip to discover new biomarkers for human atherosclerosis

Lind L., Ärnlöv J., Lindahl B. et al.

Olink Target 96CVDPatient StratificationPlasma

Journal of Immunological Methods, 2015
The effects of age and gender on plasma levels of 63 cytokines

Larsson A., Carlsson L., Gordh T. et al.

Olink Target 96Wider Proteomics StudiesEpidemiologyPlasma

Biomolecular Detection and Quantification, 2015
Proximity assays for sensitive quantification of proteins

Greenwood C., Ruff D., Kirvell S. et al.

Technical StudiesTechnology Evaluation

Arteriosclerosis, Thrombosis, and Vascular Biology, 2015
Elevated Plasma Levels of MMP-12 Are Associated With Atherosclerotic Burden and Symptomatic Cardiovascular Disease in Subjects With Type 2 Diabetes

Goncalves I., Bengtsson E., Colhoun H. et al.

Olink Target 96Metabolic DiseasesCVDPatient StratificationPlasma

Clinical Proteomics, 2015
A novel multiplexed immunoassay identifies CEA, IL-8 and prolactin as prospective markers for Dukes’ stages A-D colorectal cancers

Mahboob S., Ahn S., Cheruku H. et al.

Olink Target 96OncologyPatient StratificationPlasma

Molecular Cancer Therapeutics, 2015
The Tyrosine Kinase Inhibitors Imatinib and Dasatinib Reduce Myeloid Suppressor Cells and Release Effector Lymphocyte Responses

Christiansson L., Söderlund S., Mangsbo S. et al.

Olink Target 96OncologyTechnology EvaluationPlasma

Frontiers in Neurology, 2014
Cerebral Microdialysis for Protein Biomarker Monitoring in the Neurointensive Care Setting – A Technical Approach

Hillered L., Dahlin A., Clausen F. et al.

NeurologyTechnology Evaluation

International Orthopaedics, 2014
Exogenous BMP7 corrects plasma iron overload and bone loss in Bmp6-/- mice

Pauk M., Grgurevic L., Brkljacic J. et al.

Olink Target 96Other Diseases & SyndromesPathophysiologySerum

PLoS ONE, 2014
Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability

Assarsson E., Lundberg M., Holmquist G. et al.

PROTEOMICS, 2014
Antibody‐based proteomics and biomarker research—Current status and limitations

Solier C., Langen H.

Technical StudiesTechnology Evaluation

3556 publications